FDA Developing Timeline for Track-and-Trace Implementation

Washington Drug Letter
A A
With the new pharmaceutical track-and-trace law’s deadline for lot-level pedigrees looming, the FDA is still unclear about how it will regulate the complex requirement.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00